Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 irinotecan, leucovorin, and 5-fluorouracil for advanced gastric adenocarcinoma
ACTRN12605000706673Phase 2Completed
- Sponsor
- Site - Investigator Initiated . AGITG sponsored trial, conducted through NHMRC CTC
- Start
- Jun 1998
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan, folinic acid and fluorouracil in gastric cancer (GC), sponsored by Site - Investigator Initiated . AGITG sponsored trial, conducted through NHMRC CTC. Primary endpoint: Objective response rate. Started Jun 1998; status: completed.
02
Drugs
irinotecanfolinic acidfluorouracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ACTRN12605000706673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000706673.